searchlore

Back to Resource

All Segments

John Abramson: Big Pharma | Lex Fridman Podcast #263

John Abramson: Big Pharma | Lex Fridman Podcast #263

66 segments available

John Abramson is faculty at Harvard Medical School and a family physician for over two decades. He's the author of the new book Sickening about how big pharma broke American healthcare and how we can fix it. Please support this podcast by checking out our sponsors: - Noom: https://trynoom.com/lex - Notion: https://notion.com/startups to get up to $1000 off team plan - InsideTracker: https://insidetracker.com/lex and use code Lex25 to get 25% off - Athletic Greens: https://athleticgreens.com/lex and use code LEX to get 1 month of fish oil - Onnit: https://lexfridman.com/onnit to get up to 10% off EPISODE LINKS: John's Website: https://hcp.hms.harvard.edu/people/john-david-abramson Sickening (book): https://amzn.to/3gsVHef Overdosed America (book): https://amzn.to/3LmrWKn PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ Full episodes playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 Clips playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOeciFP3CBCIEElOJeitOr41 OUTLINE: 0:00 - Introduction 7:52 - Biggest problem with big pharma 16:54 - Advertising 36:45 - Corruption 53:01 - Pfizer vaccine data 1:01:53 - Vaccine profits 1:12:48 - Censorship 1:33:34 - FDA 1:42:09 - NIH 1:51:06 - Live longer 1:54:36 - Medications 2:03:00 - Doctors 2:07:07 - Advice for young people 2:08:03 - Big pharma's influence 2:12:47 - Mortality 2:14:38 - Meaning of life SOCIAL: - Twitter: https://twitter.com/lexfridman - LinkedIn: https://www.linkedin.com/in/lexfridman - Facebook: https://www.facebook.com/lexfridman - Instagram: https://www.instagram.com/lexfridman - Medium: https://medium.com/@lexfridman - Reddit: https://reddit.com/r/lexfridman - Support on Patreon: https://www.patreon.com/lexfridman

Segments Timeline

1
0:00 - 2:14
2:14 duration342 words

The Dark Side of Big Pharma

John Abramson discusses the pervasive issues within the pharmaceutical industry, highlighting how companies like Pfizer prioritize profits over patient care. He emphasizes the need for a rebalancing of interests to ensure healthcare serves the American people rather than shareholders.

"the jury found pfizer guilty of fraud and racketeering violations how does big farm affect your mind everyone's allowed their own opinion i don't think everyone's allowed their own scientific facts de..."

2
2:14 - 4:02
1:47 duration253 words

Understanding Human Nature in Pharma

Abramson explores the complexities of human nature within the pharmaceutical industry, arguing that while many individuals enter the field with good intentions, the corporate culture often leads to unethical practices. He discusses how the drive for profit can corrupt even the best intentions.

"and more attacked from all sides i will get attacked when i host people like jay bhattacharya or francis collins jamie mertzel or vincent ruckanyello when i stand for my friend joe rogan when i host t..."

3
4:02 - 6:11
2:09 duration349 words

The Need for Guardrails in Healthcare

In this segment, Abramson stresses the importance of implementing guardrails in the healthcare system to maintain integrity and balance. He compares the lack of oversight in American healthcare to a basketball game without referees, emphasizing the need for accountability.

"i only had one hour and so this wasn't the time to address these issues deeply but to show if albert struggled with them in the privacy of his own mind and if he would let down the veil of political s..."

4
6:11 - 8:14
2:03 duration307 words

Capitalism's Role in Healthcare

Abramson critiques the failures of capitalism in healthcare, referencing Milton Friedman's views on government functions. He argues that the pharmaceutical industry routinely violates laws and that the current system prioritizes profit over patient welfare, leading to systemic issues.

"second these conversations with leaders can be aided by further conversations with people who wrote books about those leaders or their industries those that can steal man each perspective and attempt ..."

5
8:14 - 10:01
1:47 duration263 words

The Culture of Profit in Pharma

This segment delves into the cultural milieu of the pharmaceutical industry, where maximizing shareholder returns often overshadows ethical considerations. Abramson discusses how this environment influences behavior and decision-making within companies like Pfizer.

"first question what is the biggest problem with big pharma that if fixed would be the most impactful so if you can snap your fingers and fix one thing what would be the most impactful you think the bi..."

6
10:01 - 12:02
2:00 duration261 words

Legal Violations and Accountability

Abramson outlines the legal violations committed by pharmaceutical companies, citing Pfizer's history of fraud and racketeering. He highlights the inadequacy of fines as a deterrent and the lack of accountability for executives involved in unethical practices.

"are in charge we don't have those referees in american health care that's the biggest um way that american health care is distinguished from health care and other wealthy nations so okay so you mentio..."

7
12:02 - 14:01
1:58 duration245 words

The Illusion of Ethical Business Practices

In this segment, Abramson critiques the notion of ethical business practices within the pharmaceutical industry. He argues that while companies may adhere to legal standards, their marketing strategies often mislead the public about the true benefits and risks of their products.

"in terms of violating the law it's a routine occurrence the drug companies have paid 38 billion dollars worth of fines from i think 1991 to 2017. it's never been enough to stop the uh misrepresentatio..."

8
14:01 - 16:02
2:00 duration249 words

The Impact of Advertising on Perception

Abramson discusses the effects of pharmaceutical advertising on public perception, arguing that aggressive marketing creates unrealistic expectations about drug efficacy. He emphasizes the need for transparency and honesty in how medications are presented to consumers.

"and then we look at the outcomes that you're describing and uh it looks and that's why the narrative takes hold that like pfizer ceo albert brola who i talked to is malevolent the sense is like these ..."

9
16:02 - 18:14
2:12 duration321 words

Navigating the Ethics of Pharma Advertising

This segment focuses on the ethical dilemmas surrounding pharmaceutical advertising. Abramson critiques the practices that prioritize profit over patient welfare, highlighting the need for a cultural shift within the industry to prioritize ethical considerations.

"they're playing modifies the culture you know of inside the meetings inside the rooms day to day that there's a bubble that forms like we're all in bubbles of different sizes right and that bubble all..."

10
18:14 - 20:02
1:48 duration272 words

Self-Censorship in the Pharma Industry

Abramson addresses the issue of self-censorship among healthcare professionals influenced by pharmaceutical funding. He discusses how financial ties can compromise integrity and lead to a culture where honest discourse about medications is stifled.

"because it's playing by the rules and relative to the other again it's the game relative to the other companies it's actually not that aggressive but relative to the other big pharma company yes yes i..."

11
20:29 - 22:00
1:30 duration230 words

Self-Censorship in Medical Opinions

Abramson discusses the subtle pressures faced by medical professionals funded by pharmaceutical companies, leading to self-censorship. He expresses concern over how financial ties can compromise integrity and limit the scope of critical discourse about medications, ultimately affecting public health.

"i'm actually more concerned about the effect of advertisement in a kind of much larger scale on the people that are getting funded by the advertisement in self-censorship just like more subtle more uh..."

12
22:00 - 24:28
2:28 duration382 words

The Cost of Trulicity vs. Lifestyle Changes

In this segment, Abramson compares the diabetes drug Trulicity with lifestyle changes, revealing the stark difference in cost and effectiveness. He emphasizes that while Trulicity is marketed for its cardiovascular benefits, lifestyle interventions have proven to be more effective and cost-efficient in preventing diabetes-related complications.

"on the news media on the journalists on scientists that's scary to me um but of course the direct advertisement to consumers like you said is a potentially very negative effect i i wanted to ask if um..."

13
24:28 - 26:01
1:32 duration230 words

The Need for Comparative Studies

Abramson argues for the necessity of comparative studies between pharmaceuticals and lifestyle changes in advertising. He critiques the current system that allows drug companies to promote their products without adequately addressing alternative, non-pharmaceutical interventions that could be more beneficial for patients.

"now this to be fair to the company the sponsor there's never been a study that uh compared trulicity to lifestyle changes but that's part of the problem of our advertising you would think in a rationa..."

14
26:01 - 28:03
2:02 duration322 words

The Market's Role in Health Solutions

This segment explores the limitations of market-driven solutions in healthcare. Abramson stresses the importance of prioritizing public health over corporate interests, advocating for a shift in focus towards improving overall health outcomes rather than merely promoting pharmaceutical sales.

"right and that study was done actually in the 90s it's called the diabetes prevention program it was federally funded uh by the nih so that there wasn't this drug company imperative to just try to pro..."

15
28:03 - 30:00
1:57 duration291 words

The Influence of Lifestyle Advocates

Abramson acknowledges the role of influential voices, like Joe Rogan, in promoting lifestyle changes as a counter to big pharma's influence. He highlights the need for these messages to gain traction within the medical establishment to effect real change in health policy.

"lot of our discussions about health policy right that's exactly right and the answer is that we assume that the market has to solve all these problems and the market can't solve all these problems the..."

16
30:00 - 32:14
2:13 duration342 words

The Flaws in Peer Review

In this segment, Abramson critiques the peer review process in medical research, pointing out that reviewers often lack access to raw data. He argues that this can lead to a misrepresentation of findings, ultimately affecting the quality of evidence-based medicine and the trust placed in published studies.

"until it has the legitimacy of the medical establishment yeah like something that the doctors really pay attention to well there's there's an entire mechanism established for testing drugs there's not..."

17
32:14 - 34:41
2:26 duration385 words

Truth in Pharmaceutical Advertising

Abramson proposes that pharmaceutical advertisements should include independent evaluations of their claims. He emphasizes the need for transparency regarding the effectiveness and costs of drugs compared to lifestyle changes, advocating for stricter regulations to protect consumers from misleading information.

"purpose of that study is to sell trulicity it's not to prevent cardiovascular disease you know if if we were in charge i would try to convince you that anywhere that study the results of that study we..."

18
36:08 - 37:43
1:34 duration229 words

The Dark Side of Pharma Advertising

John Abramson critiques the deceptive nature of pharmaceutical advertisements, emphasizing the need for stricter regulations. He discusses how these ads often mislead both the public and healthcare professionals, highlighting the importance of transparency in medical information.

"um just these details very strict guardrails of what actually has to be specified and i would make it against the law to have family picnics or dogs catching frisbees in the ads so you mean 95 of the ..."

19
37:43 - 39:05
1:22 duration182 words

The Flaws in Peer Review

Abramson reveals the shortcomings of the peer review process in medical research. He explains that peer reviewers often lack access to the raw data, leading to potential inaccuracies in published studies and guidelines that doctors rely on for evidence-based medicine.

"number one the information that comes through legitimate sources that doctors have been taught to rely on evidence-based medicine the articles in peer-reviewed journals the guidelines that are issued ..."

20
39:05 - 40:48
1:43 duration250 words

Manipulation of Clinical Data

In this segment, Abramson discusses the manipulation of clinical trial data by pharmaceutical companies. He shares a case study of Vioxx, illustrating how critical data was omitted, which ultimately misled both the FDA and healthcare providers about the drug's safety.

"they can't do it and then we have the clinical practice guidelines which are increasingly more important as the information the flow of information keeps getting brisker and brisker and docs need to g..."

21
40:48 - 42:56
2:07 duration331 words

The Consequences of Data Omission

Abramson elaborates on the consequences of omitting data in clinical trials, using the Vioxx case as an example. He explains how the exclusion of heart attack data skewed the results, leading to a false perception of the drug's safety and efficacy.

"spent about 10 years in litigation and for example in vioxx which was withdrawn from the market in 2004 in the biggest drug recall in american history the problem was that it got recalled when a study..."

22
42:56 - 44:22
1:25 duration199 words

Ethics in Pharmaceutical Research

This segment dives into the ethical dilemmas faced by researchers and pharmaceutical companies. Abramson questions the motivations behind data manipulation and the moral responsibilities of those involved in clinical trials.

"attacks been included the only conclusion that merck could have made was that vioxx significantly increased the risk of heart attack and they abbreviated their endpoint from heart attacks strokes and ..."

23
44:22 - 46:13
1:50 duration259 words

Integrity in Medicine

Abramson emphasizes the importance of integrity in the medical field. He advocates for small acts of heroism among healthcare professionals to challenge unethical practices and ensure that patient welfare remains the priority.

"safety monitoring board issued a letter that said they'll stop counting cardiovascular events a month before the trial is over and they'll continue counting gi events and that person got a contract to..."

24
46:13 - 48:02
1:49 duration256 words

The Role of Peer Reviewers

In this segment, Abramson discusses the role of peer reviewers in the publication process. He argues for greater transparency and accountability, suggesting that peer reviewers should have access to raw data to ensure the accuracy of published research.

"think what is the right thing to do here but the data hiding the data makes it too easy to live in ignorance so like within those inside those companies so your idea is that the reviewer should see th..."

25
48:02 - 50:11
2:08 duration329 words

Citizen Scientists and Data Transparency

Abramson advocates for the involvement of citizen scientists in analyzing clinical data. He believes that making data publicly available can lead to better scrutiny and understanding of pharmaceutical research, ultimately benefiting public health.

"peer reviewers i don't peer review clinical trials but i peer review other kinds of articles i have to do one on the airplane on the way home and it's hard i mean we're just ordinary mortal people vol..."

26
50:11 - 56:29
6:18 duration959 words

The Pfizer Vaccine Data Controversy

This segment addresses the controversy surrounding the release of Pfizer vaccine data. Abramson discusses the implications of the FDA's request for transparency and the challenges posed by pharmaceutical companies in releasing critical information.

"volunteer uh peer reviewers see i believe in even in this in the sort of capitalism or even social capital after watching twitter in the time of covid and just looking at people that investigate thems..."

27
56:10 - 58:01
1:51 duration253 words

Bureaucratic Absurdity in Vaccine Data Release

Abramson critiques the bureaucratic processes that hinder the timely release of Pfizer vaccine data. He points out the absurdity of the FDA's claims about the costs and time required to publish documents, suggesting that this reflects deeper issues within the pharmaceutical regulatory system.

"it's data doesn't matter there's details to it and i think the response from the fda is that of course yes of course uh but uh you know we can only publish like some x number of pages a day 500 pages ..."

28
58:01 - 1:00:55
2:53 duration460 words

Pro-Vaccine Yet Skeptical

Despite being pro-vaccine, Abramson expresses skepticism about the undisclosed data from Pfizer's clinical trials. He argues that the lack of transparency raises concerns about potential embarrassing findings that could undermine public trust in vaccines, while still affirming the vaccines' efficacy.

"one hour of sales and they can't come up with the money and now pfizer has joined the suit to help the fda fight off this judge this mean judge who thinks they ought to release the data but evidently ..."

29
1:00:55 - 1:03:15
2:19 duration321 words

The Political Divide on Vaccination

Abramson explores the political polarization surrounding vaccination, noting how different groups interpret vaccine data. He highlights the challenges of discerning truth amidst conflicting narratives and the influence of financial incentives on both pro- and anti-vaccine sentiments.

"and the reason why i'm not an anti-faxer having not been able to see the data that the fda and pfizer seemed to willing not just to put effort into preventing the release of but seem to have quite a b..."

30
1:03:15 - 1:05:20
2:05 duration294 words

Global Vaccine Distribution Failures

Discussing the inequities in vaccine distribution, Abramson criticizes the pharmaceutical industry's profit-driven motives that prioritize wealthy nations over global health. He warns that neglecting vaccination in developing countries could lead to the emergence of new COVID variants that threaten public health worldwide.

"anti-vaxxers can make a lot of money too let's not forget this from the individual perspective you can become famous being an anti-vaxxer and so there's a lot of incentives on all sides here and and t..."

31
1:05:20 - 1:06:43
1:22 duration169 words

Lessons from the Pfizer Vaccine Rollout

Abramson reflects on the successes and failures of the Pfizer-BioNTech vaccine rollout, acknowledging the rapid development and deployment facilitated by government funding. However, he critiques the lack of global vaccination initiatives that could have mitigated the pandemic's impact on a worldwide scale.

"drug that's ever been come along can i ask you a difficult question here in the fog that we're operating in here on the pfizer biontech vaccine what was done well and what was done badly that you can ..."

32
1:06:43 - 1:09:16
2:32 duration343 words

The Profit Motive in Pharma

In this segment, Abramson discusses the inherent conflict between profit motives and public health in the pharmaceutical industry. He argues that the focus on maximizing shareholder returns often overlooks broader societal responsibilities, particularly in the context of global health crises.

"knowledge and having that be the foundation of their product so pfizer took that and they did their r d they paid for their r d having received that technology and when they got the genetic code from ..."

33
1:09:16 - 1:12:49
3:33 duration559 words

Censorship and Public Discourse

Abramson addresses the issue of censorship in discussions about vaccines, particularly regarding voices that challenge the scientific consensus. He emphasizes the need for a balanced discourse that allows for diverse opinions while maintaining scientific integrity, especially in light of public health implications.

"have so we've made a great drug it reduces the risk of mortality in americans who get it by a lot but we're not doing what we need to do to protect americans from omicron you don't have to be an ideal..."

34
1:13:00 - 1:14:05
1:05 duration137 words

Censorship and Public Discourse

Abramson addresses the contentious issue of censorship, particularly in the context of COVID-19 vaccine discussions. He reflects on the removal of voices like Robert Malone and Peter McCullough from platforms and questions whether censorship is the right approach to managing public health discourse, advocating instead for better communication of scientific truths.

"the topic of censorship i don't know if you've uh heard but there's a guy named robert malone and peter mccalla that were removed from many platforms for speaking about the covet vaccine as being risk..."

35
1:14:05 - 1:15:00
0:54 duration123 words

The Role of Scientists in Communication

In this segment, Abramson argues that scientists must take on the responsibility of being effective communicators. He believes that rather than censoring dissenting opinions, the scientific community should focus on improving their communication skills to convey accurate information and counter misinformation.

"having too many voices that are contending here should the ultimate battle be fought in the space of uh scientific publications and particularly in the uh era of kovid where there are large public hea..."

36
1:15:00 - 1:16:30
1:30 duration189 words

The Challenge of Censorship

Abramson expresses his concerns about censorship, suggesting that it often leads to worse outcomes and is typically driven by emotional responses rather than reason. He highlights the importance of allowing open discourse and the potential dangers of empowering those who advocate for censorship.

"have a solution to this i mean ideally if we had a philosopher king we could have a panel of people who were not conflicted by rigid opinions decide on what the boundaries of public discourse might be..."

37
1:16:30 - 1:17:30
1:00 duration135 words

Building Trust in Science

This segment focuses on the need for authenticity and transparency in the scientific community to rebuild trust. Abramson argues that the way to counteract misinformation is not through censorship but by fostering a culture of open dialogue and accountability among scientists.

"give power to the individual scientists and also give them the responsibility of being better educators communicators expressers of scientific ideas put pressure on them to release data to release tha..."

38
1:17:30 - 1:18:30
1:00 duration147 words

Navigating Vaccine Discourse

Abramson discusses the polarized discourse surrounding vaccines, emphasizing the need for a rational middle ground. He critiques both extremes of the debate and calls for a more constructive conversation that prioritizes public health and understanding.

"is there's a deep distrust of institutions deep distressed the scientists of science as an institution of uh power centers of companies of of everything and perhaps rightly so but the way to defend ag..."

39
1:18:30 - 1:19:30
1:00 duration147 words

The Role of Social Media in Public Health

In this segment, Abramson reflects on the influence of social media platforms in shaping public health conversations. He argues that these platforms should facilitate healthy discourse rather than censoring it, allowing for a diversity of opinions to be expressed and evaluated.

"the people that get the most emotional and the most outraged will drive the censorship and it doesn't seem like reason drives a censorship that's just objectively observing how censorship seems to wor..."

40
1:19:30 - 1:20:30
1:00 duration133 words

The Importance of Open Discourse

Abramson emphasizes the necessity of open discourse in scientific discussions, particularly regarding vaccines. He believes that allowing all voices to be heard, including dissenting opinions, is crucial for the advancement of public understanding and trust in science.

"the the the whiny c students controlling too much of the censorship i i believe that you should you should actually put the responsibility on the self-proclaimed holders of truth aka scientists at bei..."

41
1:20:30 - 1:21:30
1:00 duration159 words

Real-Time Fact-Checking in Conversations

This segment explores the idea of real-time fact-checking during discussions, particularly in podcasts. Abramson suggests that having independent experts verify claims made during conversations could enhance the quality of public discourse and help audiences discern credible information.

"it's a question of building the commons ideally i don't know how to get there so i'm not pretending to have a solution but the commons of discourse about this particular issue about vaccines is has be..."

42
1:21:30 - 1:22:30
1:00 duration181 words

The Challenge of Balancing Perspectives

Abramson discusses the difficulty of balancing perspectives in public conversations, especially when dealing with controversial topics like vaccines. He advocates for a thoughtful approach that allows for diverse viewpoints while maintaining a commitment to scientific integrity.

"is a thing that joe rogan is currently going through as a platform whether to censor the conversation that for example joe's having so i don't know if you heard but neil young and other musicians have..."

43
1:22:30 - 1:23:30
1:00 duration146 words

The Role of Collective Intelligence

In this segment, Abramson highlights the potential of collective intelligence in addressing complex issues. He believes that when individuals engage in open discussions, they can collectively work towards understanding and truth, fostering a healthier public discourse.

"actually going to be affected by the results of the our pursuit of scientific truth right um and listen to those voices i also believe that most people are intelligent enough to process information an..."

44
1:23:30 - 1:24:30
1:00 duration154 words

The Importance of Humility in Science

Abramson concludes by stressing the importance of humility in the scientific community. He argues that scientists should be open to revising their views based on new evidence and that fostering an environment of open dialogue can facilitate this growth.

"that's where social media can be very good at like this collective intelligence we together listen to all these voices and make up our own mind humble ourselves actually often you know you think you k..."

45
1:30:05 - 1:31:15
1:10 duration194 words

The Importance of Peer Review in Conversations

John Abramson discusses the value of allowing peer review before publishing ideas, emphasizing the need for conversations to breathe and for diverse voices to contribute. He suggests that incorporating peer reviews into podcasts could enhance the quality of discussions and arguments presented.

"difficult and it's not difficult but it kind of ruins the conversation because you want the idea to breathe yeah i think what's very possible is before it's published it's the pre-publication before i..."

46
1:31:15 - 1:32:39
1:24 duration223 words

Listening to Flat Earthers: A Lesson in Persuasion

Abramson reflects on the persuasive arguments made by flat earthers, highlighting how easily people can be convinced by charismatic rhetoric. He draws parallels between this phenomenon and public health discussions, stressing the importance of critical thinking in the face of misinformation.

"on some point in terms of anti-vaxx i've been fascinated by listening to arguments from uh this community of folks that's been quite large called flat earthers the people that believe the earth is fla..."

47
1:32:39 - 1:33:34
0:54 duration171 words

Public Health Crisis: Beyond Flat Earth Theories

In the context of the COVID-19 pandemic, Abramson emphasizes the severity of the public health crisis, comparing it to the Spanish flu. He argues that discussions about public health should not be trivialized and that the stakes involve millions of lives.

"by uh uh charismatic uh arguments right and if we're arguing about whether the fla earth is flat or not uh as long as we're not navigating airplanes and doing other kinds of things trying to get satel..."

48
1:33:34 - 1:34:50
1:16 duration180 words

Revolving Doors: Pharma and Regulatory Agencies

Abramson raises concerns about the revolving door between pharmaceutical companies and regulatory agencies like the FDA and CDC. He questions the integrity of the approval process, citing the case of the Alzheimer's drug Aduhelm, which was approved despite unanimous opposition from an advisory committee.

"let me ask you yet another question that issue i raised with faisal ceo albert berla it's the question of revolving doors that there seems to be a revolving door between pfizer fda and cdc people that..."

49
1:34:50 - 1:36:31
1:40 duration200 words

The Controversy of Aduhelm's Approval

Discussing Aduhelm, Abramson details the FDA's controversial decision to approve the drug despite evidence showing it provided no meaningful benefit. He highlights the implications of this decision and the potential conflicts of interest within the FDA's advisory committees.

"and biogen showed that its drug agilem reduces amyloid plaques in the brain they did two clinical trials to determine the clinical efficacy and they found that neither trial showed a meaningful benefi..."

50
1:36:31 - 1:38:16
1:44 duration242 words

Financial Conflicts of Interest in Drug Approval

Abramson critiques the FDA's stance on financial conflicts of interest, arguing that they should be strictly prohibited in advisory committees. He discusses the implications of allowing such conflicts and the need for unbiased decision-making in drug approvals.

"we're not going to participate in this and the argument against approval is that the surrogate endpoint the reduction of amyloid the progression of amyloid plaques is known by the fda not to be a vali..."

51
1:38:16 - 1:39:59
1:42 duration266 words

The Need for a Ban on Pharma Influence

Abramson advocates for a ban on individuals transitioning between pharmaceutical companies and regulatory agencies. He argues that this practice undermines public trust and the integrity of the drug approval process.

"conflict of interest it's kind of like it's not like like like uh albert said there's rules i mean you're not allowed to have direct financial conflicts of interest it's it's indirect right but what i..."

52
1:39:59 - 1:41:43
1:44 duration277 words

NIH's Role in Drug Development

Abramson discusses the National Institutes of Health (NIH) and its critical role in drug development. He emphasizes the need for the NIH to focus on public health and preventive medicine rather than solely on drug development.

"research thinks that that's going to give you a biased result because we don't have company influence and that i think shows how how biased their thinking is that not having company influence is a bia..."

53
1:41:43 - 1:43:36
1:53 duration273 words

Rebalancing Research Towards Public Health

Abramson argues for a shift in research priorities at the NIH towards improving population health. He highlights the importance of investing in preventive medicine and lifestyle changes to enhance overall health outcomes.

"means ways and means committee in the house played a key role in ushering this through with the non-negotiation clause of it and after it was passed billy thousand did not finish out his term in congr..."

54
1:43:36 - 1:45:59
2:22 duration353 words

The Disconnect Between Spending and Health Outcomes

Abramson presents data showing the U.S. spends significantly more on healthcare than other countries yet ranks poorly in health outcomes. He critiques the current healthcare system for prioritizing profit over effective health solutions.

"that's our model now 96 of the research that's done in clinical trials in the united states is about drugs and devices and only a fraction of the four percent that's left over is about preventive medi..."

55
1:45:59 - 1:50:29
4:30 duration606 words

Healthcare Spending vs. Performance

In a detailed analysis, Abramson compares healthcare spending in the U.S. to its performance, illustrating how high spending does not correlate with better health outcomes. He calls for a reevaluation of how healthcare resources are allocated.

"and more and then that communicates i mean everything that anthony fauci says that francis collins says has an impact on scientists i mean the you know it it sets the priorities i i don't think they i..."

56
1:50:14 - 1:51:06
0:51 duration137 words

Lifestyle Choices and Longevity

As a physician, Abramson shares insights on how lifestyle choices impact health and longevity. He outlines key recommendations for living a healthier life, including regular exercise, avoiding smoking, and maintaining a healthy weight, while also acknowledging the socioeconomic factors that can hinder these choices.

"that is abiding by spending that is directed by the most profitable ways to deliver health care so you put that in the hands of big pharma is you maximize for profit you're going to decrease performan..."

57
1:51:06 - 1:52:45
1:38 duration216 words

The Challenge of Over-Prescribing

Abramson addresses the issue of over-prescribing antidepressants, discussing the complexities of treating depression. He highlights the distinction between major depression and less severe forms, arguing that many individuals are being prescribed medication without sufficient evidence of its effectiveness for their condition.

"ask you the big so as a physician the so everything you've seen we've talked about 80 percent of the impact on health is lifestyle how do we live longer what advice would you give to general people wh..."

58
1:52:45 - 2:01:01
8:15 duration1159 words

Medicalizing Normal Emotions

In this segment, Abramson critiques the medicalization of normal emotional experiences, emphasizing that feelings of sadness should not automatically lead to medication. He advocates for a more nuanced understanding of mental health, suggesting that therapy and lifestyle changes may be more effective than pharmaceuticals for many individuals.

"back to your fishbowl analogy if you're swimming in a fishbowl if you live in a fish tank that's not being properly maintained the approach wouldn't be to treat individual sick fish it would be to fix..."

59
2:01:01 - 2:02:40
1:39 duration256 words

The Role of Physicians in Patient Care

Abramson reflects on the responsibilities of physicians in addressing patient suffering while navigating the complexities of the healthcare system. He discusses the importance of understanding the root causes of patients' emotional distress and the need for a holistic approach to treatment.

"how do you overcome depression well you have to talk about what the problem is so talk therapy lifestyle changes well no i'm not jumping to that i'm saying that you ought to a the way you feel must be..."

60
2:02:40 - 2:03:39
0:59 duration130 words

The Human Connection in Medicine

In this heartfelt segment, Abramson shares his belief in the profound impact that individual patient care can have on the world. He emphasizes the importance of empathy and human connection in medicine, suggesting that the dedication to helping one person can lead to broader societal benefits.

"figure out make a diagnosis first the diagnosis isn't that the person feels sadder than they feel than they want to feel the diagnosis is why does the person feel sadder than they want to feel you men..."

61
2:03:39 - 2:05:07
1:27 duration207 words

Balancing Individual Care with Public Health

Abramson discusses the tension between providing individual patient care and the broader responsibility of physicians to allocate resources effectively for public health. He illustrates the ethical dilemmas faced by doctors when making decisions that affect both individual patients and the larger population.

"a great doctor despite all that just forgets it all and just cares about the one human and somehow that feels like the love and effort you put into helping one person is the thing that will save the w..."

62
2:05:07 - 2:07:02
1:55 duration299 words

Navigating Pharmaceutical Influence

In this segment, Abramson warns about the potential for big pharma to manipulate healthcare providers' intentions to help patients. He stresses the importance of being aware of the influences that can affect medical decisions and the need for healthcare professionals to remain vigilant against such pressures.

"patient i i wouldn't say that i think it's your responsibility torture that's exactly right the human condition that's a tough job but yeah yeah to maintain your humanity through it all yeah but you'v..."

63
2:07:02 - 2:08:39
1:36 duration220 words

Advice for Future Medical Professionals

Abramson offers guidance to young individuals considering a career in medicine, emphasizing the importance of passion and genuine care for patients. He encourages those with a calling to pursue medicine, while cautioning against entering the field solely for financial gain.

"and you need to opt out of it what advice would you give to a young person today in high school or college stepping into this complicated world full of advertisements of big powerful institutions of b..."

64
2:09:12 - 2:12:12
2:59 duration455 words

The Crisis of American Healthcare

Abramson articulates the dire state of American healthcare, attributing its decline to the financial exploitation by the pharmaceutical industry. He shares personal anecdotes and insights from his book 'Sickening,' aiming to raise awareness about the systemic issues that undermine the health of Americans and the need for reform.

"the thing that is normal not question the normal don't uh if you conform conform hesitantly well you have to conform you can't become a doctor without conforming um i i i just made it through but ther..."

65
2:12:50 - 2:15:29
2:39 duration369 words

Reflections on Mortality and Meaning

In a profound discussion, Abramson shares his thoughts on mortality and the meaning of life. He reflects on his near-death experience and the liberation it brought him, emphasizing the importance of committing oneself to meaningful pursuits that contribute positively to the world.

"as an educator live better lives live longer but you yourself are a mortal being do you think about your own mortality do you think about your death are you afraid of death oh yeah um i'm not i've fac..."

66
2:15:31 - 2:17:18
1:47 duration291 words

Closing Thoughts and Gratitude

As the conversation wraps up, Abramson expresses gratitude for the opportunity to discuss critical issues in healthcare and education. He encourages listeners to engage with serious ideas and reflects on the importance of mentorship and learning from great educators, leaving the audience with a powerful quote from Marcus Aurelius.

"heart and soul into the thing yep what is it the bukowski poem go all the way john um you're an incredible human being incredible educator like i said i recommend people listen to your lectures it's i..."